18F-FDG PET—CT作为一种反映能量代谢底物葡萄糖跨膜转运速率和数量的分子影像技术,目前已经被作为恶性淋巴瘤的初始分期、再分期及疗效随访的标准影像技术。但其在淋巴瘤疗效评价及预后中的应用价值尚未明确,该文就近年来18F—FDG PET—CT在淋巴瘤疗效评价及预后中的研究进展进行综述。
18F-FDG PET-CT as a molecular imaging technology for velocity rate and quantity of FDG has become a standard imaging technique for staging and follow-up of lymphoma. However, its value in therapy evaluation and prognosis is not very clear. This article summarizes some related papers in recent years and reviews its value in therapy evaluation and prognosis of lymphoma.